Chantret I, Chevalier G, Dussaulx E, Zweibaum A
Cancer Res. 1987 Mar 1;47(5):1426-33.
The purpose of this work was to investigate whether sucrase-isomaltase from enterocyte-like differentiated human colon carcinoma cell lines carries blood group antigens of the ABH system. Six cultured lines of blood group A (HT-29, SW-480, Co-115) or O phenotype (Caco-2, HRT-18, HCT-8R) were studied. Only HT-29 cells grown in the absence of glucose (HT-29 Glc-) and Caco-2 cells express an enterocytic differentiation with the presence of sucrase-isomaltase on the apical surface of the cells. Binding of anti-A antibodies to HT-29 Glc- and of UEA-I to Caco-2 cells gave the same apical immunofluorescence pattern of staining as did anti-sucrase-isomaltase antibodies, whereas only a membrane binding was observed in nondifferentiated cells. Sucrase-isomaltase immunoisolated from HT-29 Glc- and Caco-2 cells reacted with anti-A antibodies and Ulex europaeus agglutinin-I (UEA-I), respectively, at sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblot. Immunoprecipitation of solubilized brush border-enriched fractions from the same cells with UEA-I or anti-A antibodies resulted in an inhibition of sucrase activity which reached congruent to 80% for Caco-2 cells with UEA-I and approximately equal to 50% for HT-29 cells with anti-A antibodies. Similar results were obtained in the corresponding tumors in nude mice: anti-A antibodies in HT-29 and UEA-I in Caco-2 tumors bound to the same apical structures as did anti-sucrase-isomaltase antibodies; sucrase-isomaltase immunoisolated from the tumors bound anti-A antibodies (HT-29) or UEA-I (Caco-2). These results support the hypothesis that sucrase-isomaltase from enterocyte-like differentiated human colon cancer cells carries blood group antigens of the ABH system. These findings suggest that colon cancers which have been shown to display an apical pattern of expression of ABH antigens should be screened for their possible enterocytic differentiation.
本研究旨在探究来自肠细胞样分化的人结肠癌细胞系的蔗糖酶-异麦芽糖酶是否携带ABH系统血型抗原。研究了6种血型为A(HT-29、SW-480、Co-115)或O(Caco-2、HRT-18、HCT-8R)表型的培养细胞系。只有在无葡萄糖条件下生长的HT-29细胞(HT-29 Glc-)和Caco-2细胞在细胞顶端表面表达蔗糖酶-异麦芽糖酶,呈现肠细胞样分化。抗A抗体与HT-29 Glc-细胞的结合以及UEA-I与Caco-2细胞的结合,产生了与抗蔗糖酶-异麦芽糖酶抗体相同的顶端免疫荧光染色模式,而在未分化细胞中仅观察到膜结合。从HT-29 Glc-和Caco-2细胞中免疫分离的蔗糖酶-异麦芽糖酶,在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳和免疫印迹中分别与抗A抗体和欧洲荆豆凝集素-I(UEA-I)发生反应。用UEA-I或抗A抗体对来自相同细胞的溶解的富含刷状缘的组分进行免疫沉淀,导致蔗糖酶活性受到抑制,对于Caco-2细胞,用UEA-I时抑制率达到约80%,对于HT-29细胞,用抗A抗体时抑制率约为50%。在裸鼠的相应肿瘤中也获得了类似结果:HT-29肿瘤中的抗A抗体和Caco-2肿瘤中的UEA-I与抗蔗糖酶-异麦芽糖酶抗体结合到相同的顶端结构;从肿瘤中免疫分离的蔗糖酶-异麦芽糖酶结合抗A抗体(HT-29)或UEA-I(Caco-2)。这些结果支持了以下假说:来自肠细胞样分化的人结肠癌细胞的蔗糖酶-异麦芽糖酶携带ABH系统血型抗原。这些发现表明,已显示出ABH抗原顶端表达模式的结肠癌应筛查其可能的肠细胞样分化情况。